BG64317B1 - Глюкокортикоид-селективни противовъзпалителни средства - Google Patents

Глюкокортикоид-селективни противовъзпалителни средства Download PDF

Info

Publication number
BG64317B1
BG64317B1 BG104719A BG10471900A BG64317B1 BG 64317 B1 BG64317 B1 BG 64317B1 BG 104719 A BG104719 A BG 104719A BG 10471900 A BG10471900 A BG 10471900A BG 64317 B1 BG64317 B1 BG 64317B1
Authority
BG
Bulgaria
Prior art keywords
dihydro
trimethyl
quinoline
methoxy
benzopyrano
Prior art date
Application number
BG104719A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG104719A (en
Inventor
Michael J. Coughlan
Steven W. Elmore
Michael E. Kort
Philip R. Kym
Jimmie L. Moore
John K. Pratt
Alan X. Wang
James P. Edwards
Todd K. Jones
Original Assignee
Abbott Laboratories
Ligand Pharmaceuticals,Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories, Ligand Pharmaceuticals,Inc filed Critical Abbott Laboratories
Publication of BG104719A publication Critical patent/BG104719A/xx
Publication of BG64317B1 publication Critical patent/BG64317B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
BG104719A 1998-02-13 2000-08-28 Глюкокортикоид-селективни противовъзпалителни средства BG64317B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (2)

Publication Number Publication Date
BG104719A BG104719A (en) 2001-05-31
BG64317B1 true BG64317B1 (bg) 2004-09-30

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104719A BG64317B1 (bg) 1998-02-13 2000-08-28 Глюкокортикоид-селективни противовъзпалителни средства

Country Status (21)

Country Link
EP (1) EP1053239B1 (es)
JP (1) JP2002503665A (es)
KR (1) KR20010040935A (es)
CN (1) CN1119348C (es)
AT (1) ATE230749T1 (es)
AU (1) AU766441B2 (es)
BG (1) BG64317B1 (es)
BR (1) BR9907788A (es)
CA (1) CA2320943A1 (es)
DE (1) DE69904804T2 (es)
DK (1) DK1053239T3 (es)
ES (1) ES2192035T3 (es)
HK (1) HK1033308A1 (es)
HU (1) HUP0100460A3 (es)
IL (1) IL137508A0 (es)
NO (1) NO20004053L (es)
NZ (1) NZ506013A (es)
PL (1) PL193323B1 (es)
SK (1) SK284689B6 (es)
TR (1) TR200003094T2 (es)
WO (1) WO1999041256A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
DE60309829T2 (de) 2002-01-14 2007-09-13 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
MXPA04009329A (es) 2002-03-26 2005-01-25 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y usos de los mismos.
US7268152B2 (en) 2002-03-26 2007-09-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE60335869D1 (de) 2002-04-11 2011-03-10 Merck Sharp & Dohme 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2003259747A1 (en) 2002-08-21 2004-03-11 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
WO2004033459A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
JP2006508076A (ja) * 2002-10-11 2006-03-09 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的プロゲステロン受容体モジュレーター化合物としての5−シクロアルケニル5H−クロメノ[3,4−f]キノリン誘導体
JP4373926B2 (ja) 2003-01-03 2009-11-25 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 1−プロパノール及び1−プロピルアミン誘導体ならびにグルココルチコイドリガンドとしての使用
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7507843B2 (en) 2003-10-16 2009-03-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
US7741361B2 (en) 2004-12-27 2010-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US8017775B2 (en) * 2005-09-14 2011-09-13 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
EP2459524A2 (en) 2009-07-31 2012-06-06 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ176197A3 (cs) * 1994-12-22 1998-09-16 Ligand Pharmaceuticals Incorporated Modulátory steroidových receptorů a způsoby jejich přípravy a použití

Also Published As

Publication number Publication date
DK1053239T3 (da) 2003-04-22
CN1296486A (zh) 2001-05-23
NO20004053D0 (no) 2000-08-11
NZ506013A (en) 2003-03-28
CN1119348C (zh) 2003-08-27
PL193323B1 (pl) 2007-02-28
HUP0100460A3 (en) 2003-03-28
AU2677399A (en) 1999-08-30
HUP0100460A2 (hu) 2001-09-28
WO1999041256A1 (en) 1999-08-19
EP1053239A1 (en) 2000-11-22
TR200003094T2 (tr) 2001-01-22
IL137508A0 (en) 2001-07-24
KR20010040935A (ko) 2001-05-15
ATE230749T1 (de) 2003-01-15
AU766441B2 (en) 2003-10-16
DE69904804D1 (de) 2003-02-13
DE69904804T2 (de) 2003-11-06
BR9907788A (pt) 2001-10-30
BG104719A (en) 2001-05-31
NO20004053L (no) 2000-09-11
ES2192035T3 (es) 2003-09-16
JP2002503665A (ja) 2002-02-05
HK1033308A1 (en) 2001-08-24
PL343018A1 (en) 2001-07-30
EP1053239B1 (en) 2003-01-08
SK11972000A3 (sk) 2001-08-06
SK284689B6 (sk) 2005-09-08
CA2320943A1 (en) 1999-09-19

Similar Documents

Publication Publication Date Title
BG64317B1 (bg) Глюкокортикоид-селективни противовъзпалителни средства
US6506766B1 (en) Glucocortiocoid-selective antinflammatory agents
EP2675812B1 (en) Chroman - spirocyclic piperidine amides as modulators of ion channels
EP3686196B1 (en) Polycyclic compound acting as ido inhibitor and/or ido-hdac dual inhibitor
EP2041142B1 (de) Spirocyclische azaindol-derivate
SG192248A1 (en) Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
AU760511B2 (en) Glucocorticoid-selective antiinflammatory agents
CN111032034A (zh) 螺环化合物及其制造和使用方法
TW200808808A (en) Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
EA027113B1 (ru) Регуляторы пути комплемента и их применение
JP2023539194A (ja) Apol1の阻害剤およびこれを使用する方法
RU2241001C2 (ru) Производные галантамина, способ их получения, лекарственное средство на их основе и способ его получения
WO1998054187A1 (en) Spiro-azacyclic derivatives and their use as therapeutic agents
AU2014300629A1 (en) Chromane and chromene derivatives and their use as CRAC modulators
KR20180109871A (ko) 아졸로 치환된 피리딘 화합물
TW214547B (es)
JPH0443917B2 (es)
WO2019035061A1 (en) NOVEL STEROIDS AND METHODS OF MAKING
AU2013240007A1 (en) Schweinfurthin analogues
KR0182296B1 (ko) 헥사하이드로피롤로[2,3-b]인돌-카바메이트, -우레아, -아미드 및 관련 화합물과 이를 함유하는 약제학적 조성물
AU2015255181A1 (en) Spiro-cyclic amine derivatives as s1p modulators
CZ20002893A3 (cs) Glukokortikoidně selektivní protizánětlivé látky
MXPA00007944A (es) Agentes anti-inflamatorios selectivos de glucocorticoide
CA2362272A1 (en) Spirocyclic ketones and their use as tachykinin antagonists
KR100768245B1 (ko) 신규한 갈란타민 유도체 및 유사체